Neutralizing interleukin-10 autoantibodies were found in a subgroup of patients with inflammatory bowel disease and in no controls without IBD. Seropositivity was strongly associated with the IBD HLA-DRB1*01:03 risk allele. Full study results: nej.md/4dXZ3od
Science behind the Study: Autoantibodies against Cytokines — From Infection to Inflammation nej.md/4e1EZ4s
ALT Bar graph from an article published in the New England Journal of Medicine article showing interleukin-10 as measured by neutralization in interleukin-10 reporter assay and ELISA. The graph compares two groups: "Total Control" with a value of 0% and "Total IBD Cohorts" at 3.5% with a confidence interval of 3.0–4.1. Statistical notation shows P<0.001.
NASPGHAN Foundation grant opportunities are available to support pediatric GI research, training, nutrition, QI, advocacy, nursing, dietitian research, and more. Explore current opportunities share with eligible colleagues. tinyurl.com/2h9xd4z6#NASPGHAN#PediatricGI
We’ve arrived in beautiful sunny Palo Alto to our lab’s new home @Stanford!
I’m incredibly excited to join the Children’s Health Center for IBD and Celiac Disease @SMCH_IBD_Celiac and @StanfordPedsGI
Hiring post-docs and staff 🔜
This got little attn. One 🤚, fantastic to have new labeled indication for kids down to 2. Other ✋, why did adult patients get it 10 years earlier? #WeCanDoBetterForKids with early PK studies, efficacy extrapolation, and use of vast real world data! jnj.com/media-center/press-r…
Attending #PAS2026? Michael J. Rosen, MD, endowed director for @StanfordChild's Center for IBD and Celiac Disease, will be delivering the keynote at the SPR Basic/ Translational Science Research Assembly on Saturday, April 25 at 8:35 a.m.
Grant opportunities open April 1. Thanks to our generous donors, the NASPGHAN Foundation supports research, clinical care, innovation, advocacy, and the next generation of leaders in pediatric GI. Explore available funding opportunities: tinyurl.com/2h9xd4z6
Looking forward to discussing the role of emerging therapies for children with IBD with @amelia_kellar, @pedsIBDdoc and others in this @NASPGHAN webinar!
Just one week away!
Make sure you’re registered for this high yield @NASPGHAN#PediatricIBD Virtual Webinar on novel therapies.
Registration available for both members and non-members! You can also earn MOC Part 2 credit.
👉 Register here:
learnonline.naspghan.org/pro…